SCHEMBL13896381

SCHEMBL13896381

CS(=O)(=O)NC(=O)[C@@]12C[C@H]1/C=C\CCCCC[C@H](NC(=O)O)C(=O)N1C[C@H](OC(=O)N3CCc4ccccc4C3)C[C@H]1C(=O)N2

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ CTSB P07858 1/20 0.36
▸ CYP3A4 P08684 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CTSS P25774 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ BCL2 P10415 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11975740 0.94 ADRB3 (0.45) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL13896371 0.93 CTSB (0.41) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL3968652 0.92 ADRB3 (0.40) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL13880421 0.92 ADRB3 (0.40) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL8278114 0.92 ADRB3 (0.40) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL11975737 0.89 ADRB3 (0.43) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL11975739 0.89 ADRB3 (0.45) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL11975931 0.88 ADRB3 (0.43) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL8278112 0.88 ADRB3 (0.42) ADRB3ADRA2BADRA2CCTSBCYP3A4
SCHEMBL11975933 0.88 ADRB3 (0.42) ADRB3ADRA2BADRA2CCTSBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1680137-B1 Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of HCV replication HOFFMANN LA ROCHE (CH) 2012-11-21 — — EP disclosed
Send feedback